Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.
about
Biomarkers in triple negative breast cancer: A reviewNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityIL-1 does not reverse the anti-proliferative effect of aspirin in breast cancer cellsInflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerNSAIDs and breast cancer recurrence in a prospective cohort studyCyclooxygenase-2 and the inflammogenesis of breast cancer.Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situNF-kappa B genes have a major role in inflammatory breast cancerAbalone visceral extract inhibit tumor growth and metastasis by modulating Cox-2 levels and CD8+ T cell activity.Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer.The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastasesPrognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.Ardisia crispa roots inhibit cyclooxygenase and suppress angiogenesisCyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications.Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neuPivotal role of vascular endothelial growth factor pathway in tumor angiogenesis.COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirinA New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3Stress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer.Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancerExpression of cyclooxygenase-2 (COX-2) in pituitary tumours.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cellsSignalling pathways involved in clinical responses to chemotherapy.Impact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients.Mechanisms linking obesity and cancerInteraction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells.MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitroInflammation and cancer: how friendly is the relationship for cancer patients?Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkersExpression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factors.Role of Cyclooxygenase 2 (COX-2) in Prognosis of Breast Cancer.Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression.Canine mammary tumours, an overview.
P2860
Q26775094-5F74F817-B683-4128-A2FC-E1F7F6703784Q28166312-12EAFC37-D18D-49E8-BCAE-6D2091110778Q28200420-CE130C50-8181-4A0F-9EBF-7EAA5F3A0F2CQ28218639-D054C11C-8168-4A6D-B2CD-16BA821B53E3Q28221965-9F1869C9-EA1C-4841-B28F-5EAB6A4DD4A5Q30367680-F5B991CC-2373-412E-A871-84841DC3245AQ31169692-0070862D-3E5E-480F-9428-3724F5E7CCECQ33314445-13A864A6-B939-4400-A372-EE629504DFB9Q33317621-796DEE5F-12A7-40E8-9A56-B851C519D87FQ33318125-8A00CF0C-4148-4A50-9B8A-0189364D009DQ33723522-AC3DEDBD-819D-4E94-B66F-598CFA446420Q33736242-E2A1736E-BBD2-42C4-B8D9-B1C08824C3FFQ33747000-C9FB2779-E5FE-4D18-9D02-46FC3BD5C6F2Q34234484-17017379-E8DC-41B9-907E-CCD1A26D8641Q34245828-6A6552F9-12E6-4DB8-B3A7-3D33507E4C91Q34996098-2411A528-52A6-4033-BF65-41734D3D146EQ35010488-392CCD5A-4A21-4E2C-9159-A7AF1CC4F4C8Q35123725-E8E79164-5E94-49DE-A300-A36DA7CDB84EQ35588568-B48D7142-A05C-4B1C-921A-7A195C0D4112Q35770111-095F956C-E8AC-4EFC-8A76-ACF7009CF81CQ35782469-9ED5F049-0AA9-41A5-872B-D8D2DBEDCBB7Q35797114-FA62FB13-ADF6-4C71-BFDA-EB1778FCD9CDQ35902645-1B5926A5-0DFD-4043-868E-7CECD7D7C19DQ35934286-0E2CABEC-8192-44D2-BE0E-1E4F48865690Q36492855-C995F0B1-1C3B-4538-9FDC-3E1512054FCDQ36577742-500B3E4E-EFA9-4536-8FFD-DCC084F5C6F9Q36694470-566E9A12-416E-4241-BC80-3104CD607951Q36787339-19F24C25-D3C9-4F13-905D-AA542CD71ED3Q36987488-3E596FC8-EBB1-4052-AF25-309A7AC237BDQ37088155-3405EFC7-6B11-4FE7-9BDE-7DE230BD55E8Q37154242-D6D53737-F648-419E-9569-A352191FC878Q37208149-512514F7-6514-4638-BE08-FAA695A8D8D3Q37228853-A3C04DFD-6782-4002-B0E2-0AFF3E404059Q37316105-4D691EEA-564C-4DC5-B2F7-E3DC5CF00A12Q37326197-9B9D5D0D-0F0A-4381-84C6-A8D5C901CBE0Q37446995-12F08ED2-4441-4A98-8C24-0BB302A8E2DFQ37660357-7AECE5E1-0C2F-4CDB-A016-68EA3957D0CDQ37701526-D094F7CA-EF2D-4171-9E8C-99D725E5379CQ37702145-9AE500D0-FC4A-4B5C-8FBE-CA348604D230Q37885436-3E63DDA9-CFB9-4160-8C5D-841630E72DD6
P2860
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Cyclo-oxygenase 2 expression i ...... stasis in human breast cancer.
@ast
Cyclo-oxygenase 2 expression i ...... stasis in human breast cancer.
@en
type
label
Cyclo-oxygenase 2 expression i ...... stasis in human breast cancer.
@ast
Cyclo-oxygenase 2 expression i ...... stasis in human breast cancer.
@en
prefLabel
Cyclo-oxygenase 2 expression i ...... stasis in human breast cancer.
@ast
Cyclo-oxygenase 2 expression i ...... stasis in human breast cancer.
@en
P2093
P2860
P356
P1476
Cyclo-oxygenase 2 expression i ...... astasis in human breast cancer
@en
P2093
I Amendoeira
J S Reis-Filho
P2860
P304
P356
10.1136/JCP.55.6.429
P407
P577
2002-06-01T00:00:00Z